Evidence map›Paper›PMID 33512094›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2021

Type I Interferon-Activated STAT4 Regulation of Follicular Helper T Cell-Dependent Cytokine and Immunoglobulin Production in Lupus.

Xuemei Dong, Olivia Q Antao, Wenzhi Song, Gina M Sanchez, Krzysztof Zembrzuski, Fotios Koumpouras, Alexander Lemenze, Joe Craft, Jason S Weinstein

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. T follicular helper cells in primary immune regulatory disorders.The Journal of allergy and clinical immunology · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. STAT4 gene polymorphisms in human diseases.Frontiers in immunology · 2024
    Review
  16. Review
  17. Article
  18. Review
  19. Endosome Traffic Modulates Pro-Inflammatory Signal Transduction in CD4International journal of molecular sciences · 2023
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xuemei DongYale University School of Medicine, New Haven, Connecticut.
Olivia Q AntaoRutgers New Jersey Medical School, Newark.
Wenzhi SongYale University School of Medicine, New Haven, Connecticut.
Gina M SanchezRutgers New Jersey Medical School, Newark.
Krzysztof ZembrzuskiRutgers New Jersey Medical School, Newark.
Fotios KoumpourasYale University School of Medicine, New Haven, Connecticut.
Alexander LemenzeRutgers New Jersey Medical School, Newark.
Joe CraftYale University School of Medicine, New Haven, Connecticut.
Jason S WeinsteinYale University School of Medicine, New Haven, Connecticut, and Rutgers New Jersey Medical School, Newark.ORCID 0000-0001-9918-2817
Rutgers, The State University of New Jersey · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
TRAINING PROGRAM IN INVESTIGATIVE RHEUMATOLOGYT32AR007107 · NIAMS · YALE UNIVERSITY · PI RICHARD J BUCALA · 1986 to 2026
$7.5M
IMMUNE RESPONSES IN LUPUSR37AR040072 · NIAMS · YALE UNIVERSITY · PI CRAFT, JOSEPH EDGAR · 2000 to 2025
$7.4M
Yale Rheumatic Diseases Research Core CenterP30AR053495 · NIAMS · YALE UNIVERSITY · PI HABERMAN, ANN M · 2007 to 2017
$7.0M
T cell regulation of pathogenic B cells in systemic autoimmunityR01AR073912 · NIAMS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Jason Weinstein · 2018 to 2026
$3.2M
Follicular Helper T Cell Function in AutoimmunityR01AR074545 · NIAMS · YALE UNIVERSITY · PI CRAFT, JOSEPH EDGAR · 2019 to 2022
$1.3M
Transcriptional Regulation of T Follicular Helper Cells in LupusK01AR067892 · NIAMS · YALE UNIVERSITY · PI WEINSTEIN, JASON · 2015 to 2019
$614k
NCATS NIH HHS UL1 TR001863NIAMS NIH HHS K01 AR067892NIAMS NIH HHS P30 AR053495NIAMS NIH HHS R01 AR073912NIAMS NIH HHS R01 AR074545NIAMS NIH HHS R37 AR040072NIAMS NIH HHS T32 AR007107
6 · The paper itself

Abstract

objectiveTo assess the role of STAT4 activation in driving pathogenic follicular helper T (Tfh) cell secretion of the cytokines interleukin-21 (IL-21) and interferon-γ (IFNγ) in murine and human lupus.

methodsThe effect of STAT4-dependent Tfh cell signaling on cytokine production and autoreactive B cell maturation was assessed temporally during the course of lupus in a murine model, with further assessment of Tfh cell gene transcription performed using RNA-Seq technology. STAT4-dependent signaling and cytokine production were also determined in circulating Tfh-like cells in patients with systemic lupus erythematosus (SLE), as compared to cells from healthy control subjects, and correlations with disease activity were assessed in the Tfh-like cells from SLE patients.

resultsIL-21- and IFNγ-coproducing Tfh cells expanded prior to the detection of potentially pathogenic IgG2c autoantibodies in lupus-prone mice. Tfh cells transcriptionally evolved during the course of disease with acquisition of a STAT4-dependent gene signature. Maintenance of Tfh cell cytokine synthesis was dependent upon STAT4 signaling, driven by type I IFNs. Circulating Tfh-like cells from patients with SLE also secreted IL-21 and IFNγ, with STAT4 phosphorylation enhanced by IFNβ, in association with the extent of clinical disease activity.

conclusionWe identified a role for type I IFN signaling in driving STAT4 activation and production of IL-21 and IFNγ by Tfh cells in murine and human lupus. Enhanced STAT4 activation in Tfh cells may underlie pathogenic B cell responses in both murine and human lupus. These data indicate that STAT4 guides pathogenic cytokine and immunoglobulin production in SLE, demonstrating a potential therapeutic target to modulate autoimmunity.

Indexed as

AdultAnimalsAntibody FormationAutoantibodiesB-LymphocytesCase-Control StudiesCytokinesDisease Models, AnimalFemaleHumansImmunoglobulinsInterferon-gammaInterferon Type IInterleukin-21InterleukinsLupus Erythematosus, SystemicAutoantibodiesCytokinesImmunoglobulinsInterferon-gammaInterferon Type IInterleukin-21InterleukinsSTAT4 protein, humanStat4 protein, mouseSTAT4 Transcription Factor

Identifiers

PMID33512094
PMCPMC7914134
OpenAlexW3125900304

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.